Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 02, 2009 07:00 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity to Present At Upcoming Conferences

CAMBRIDGE, Mass., Sept. 2, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that management will...
August 05, 2009 16:15 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Reports Recent R&D Highlights and Second Quarter 2009 Results

CAMBRIDGE, Mass., Aug. 5, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today reviewed recent R&D highlights,...
July 30, 2009 06:30 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Announces Second Quarter 2009 Results Conference Call

CAMBRIDGE, Mass., July 30, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced today that Infinity management...
July 23, 2009 16:40 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Paper On Discovery of Its Novel Hedgehog Inhibitor, IPI-926, Published in Journal of Medicinal Chemistry

-- Paper Features Chemistry and Preclinical Data Leading to Discovery of IPI-926 - Currently in Phase 1 Development -- -- Publication Follows Recent Paper in Science Demonstrating ...
June 29, 2009 06:30 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Pharmaceuticals Added to Russell 2000(r) Index

CAMBRIDGE, Mass., June 29, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that it was added to the...
May 30, 2009 14:00 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Reports Encouraging Clinical Data for IPI-504 at ASCO 2009

Phase 2 Data Show Partial Responses and Generally Well-Tolerated Safety Profile in Patients with Advanced Non-Small Cell Lung Cancer Phase 1 Study Demonstrates Combinability of IPI-504...
May 29, 2009 06:30 ET | Source: Infinity Pharmaceuticals, Inc.

New Paper in Science Features Infinity's IPI-926 Hedgehog Pathway Inhibitor as a Promising New Approach in Chemo-Resistant Pancreatic Cancer

CAMBRIDGE, Mass., May 29, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, announced the recent publication of a new...
May 27, 2009 13:00 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Pharmaceuticals Named Winner of The Scientist's 'Best Places to Work in Industry' and Featured in Boston Business Journal's Best Places to Work 2009 Survey

CAMBRIDGE, Mass., May 27, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that it has been named one...
May 13, 2009 07:30 ET | Source: Infinity Pharmaceuticals, Inc.

Clinical Data From Infinity's Hsp90 Chaperone Inhibitor Program to be Presented During ASCO Meeting

CAMBRIDGE, Mass., May 13, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that it will be reporting...
May 04, 2009 16:30 ET | Source: Infinity Pharmaceuticals, Inc.

Infinity Reports Recent Pipeline Developments and First Quarter 2009 Results

CAMBRIDGE, Mass., May 4, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today reviewed recent clinical...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right